Bradda Head  Lithium exceeds targets, secures US$3 million royalty and moves closer to production. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.42
Bid: 4.42
Ask: 4.46
Change: 0.02 (0.45%)
Spread: 0.04 (0.905%)
Open: 4.515
High: 4.515
Low: 4.38
Prev. Close: 4.40
SEE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant Approval

14 Aug 2006 10:57

Seeing Machines Limited14 August 2006 14 August 2006 SEEING MACHINES LIMITED ("Seeing Machines" or "the Company") AUSTRALIAN GOVERNMENT APPROVES GRANT APPLICATION Seeing Machines Limited (AIM: SEE), a leading developer of advanced computerbased imaging software systems, has been advised by AusIndustry that itsapplication for an Australian Federal Government Commercial Ready Grantsupporting its glaucoma diagnostic device development project has been approved,conditional on finalising normal contractual arrangements. The grant providesmatching funding of up to AUD$2.1 million over 2 years to support the continueddevelopment and commercialization of the glaucoma device. Seeing Machines' glaucoma device is a non-contact objective device designed toreliably and quickly measure a person's functional visual field. Assessingvisual field is crucial in diagnosing a range of human visual system diseases,such as glaucoma. The key advantages the Seeing Machines device has over thoseavailable on the market today are derived from the objectivity of the technique.It is non-contact, fast and greatly enhances the patient experience. Seeing Machines completed an initial research and development project for thedevice in February 2006 and this work was supported by a $250,000 AusIndustryBiotechnology Innovation Fund Grant. The company has successfully completed(June 2006) a $3.2 million R&D Start Grant project aimed at developing SeeingMachines' face and eye tracking technology to a level where deployment in theautomotive domain for the detection of fatigue and distraction is feasible. Seeing Machines CEO Nick Cerneaz said: "the Company was very pleased to beawarded the Commercial Ready Grant. The strong endorsement of our technology, R&D capabilities and the potential for successful commercialisation of thisdevice is very encouraging." He also commented on the importance of governmentprograms supporting innovation for local industry development and noted thestrong support the company had received over the years for its R&D both fromCommonwealth and local government programs. Federal Industry Minister Ian Macfarlane congratulated Seeing Machines on beingoffered the Australian Government Commercial Ready grant to develop the devicethat will make it easier to diagnose diseases affecting vision: "Diseases such as glaucoma afflict millions of people world-wide and it isdifficult to detect. Seeing Machines has a strong track record in developingtechnology in this field and the Government, through the Commercial Readyprogram, is pleased to support projects such as this." Enquiries:Seeing Machines Limited Insinger de Beaufort Parkgreen Communications Nick Cerneaz, CEO Simon Fox Justine Howarth / Victoria Thomas+61 (0) 2 6125 6501 +44 (0) 20 7190 7018 +44 (0) 20 7493 3713www.seeingmachines.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
30th Nov 20068:27 amRNSAGM Statement
9th Nov 20067:01 amRNSGlaucoma Study Re-commences
2nd Nov 20067:01 amRNSNew Product
19th Oct 20065:38 pmRNSFinal Results - Replacement
19th Oct 200611:29 amRNSFinal Results
18th Oct 200611:04 amRNSDirectorate Change
17th Oct 20063:20 pmRNSNew Version of faceLAB
21st Sep 20064:41 pmRNSIssue of Equity
18th Sep 200611:24 amRNSAutomotive progress
18th Sep 20069:45 amRNSGlaucoma Grant Signed
30th Aug 200611:46 amRNSClinical Study Results
14th Aug 200610:57 amRNSGrant Approval
6th Jul 20069:12 amRNSDirector/PDMR Shareholding
29th Jun 20069:37 amRNSEmployee Share Option Scheme
27th Jun 200610:11 amRNSGrant of US Patent
5th Jun 200610:14 amRNSHolding(s) in Company
10th May 20069:27 amRNSHolding(s) in Company
13th Apr 20063:25 pmRNSDirector/PDMR Shareholding
13th Apr 200612:47 pmRNSNew faceLAB Camera Product
10th Apr 20069:19 amRNSMajor Industry Awards Win
15th Mar 20067:01 amRNSInterim Results
3rd Mar 20069:42 amRNSAGM Statement-Amendment
28th Feb 20069:15 amRNSAGM Statement
8th Feb 20069:25 amRNSHolding(s) in Company
31st Jan 20069:30 amRNSHolding(s) in Company
25th Jan 20069:24 amRNSHolding(s) in Company
10th Jan 20069:18 amRNS1st Glaucoma Trial Completion
20th Dec 20053:46 pmRNSIssue of Equity
6th Dec 20059:41 amRNSHolding(s) in Company
1st Dec 20058:53 amRNSAdmission to AIM-Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.